Studies will be undertaken to characterize human tumor necrosis factor and its biological and biochemical effects. An assay will also be developed which will allow for a determination of the responsiveness of freshly removed tumor tissues to tumor necrosis factor. Studies proposed include the further characterization of the human tumor necrosis factor produced by the LuKII cell line (termed tumor necrosis factor (LuKII)) and a comparison o its biological and biochemical characteristics with those of other cytotoxic molecules which are being produced by recombinant technology (i.e., lymphotoxin and tumor necrosis factor). Studies will be undertaken to determine the relationship between and the characteristics of the various molecular weight forms of tumor necrosis factor (LuKII). Cells which have been made resistant to the growth inhibitory effect of tumor necrosis factor (LuKII) by selecting from a tumor necrosis factor-sensitive cell line those cells that are capable of growing in the presence of this factor have been found to release a protein into the media that blocks the binding of tumor necrosis factor (LuKII) to tumor necrosis factor-sensitive cells. The mechanism by which this molecule manifests its effect will be studied and the role this molecule plays in the natural resistance of cells to tumor necrosis factor (LuKII) will be investigated. Cells sensitive to the effects of tumor necrosis factor (LuKII) have been observed to have receptors for tumor necrosis factor (LuKII) and to synthesize new proteins in response to treatment with this factor. Based on these observations, methodologies will be developed which will allow for a determination of the responsiveness of freshly removed tumor tissues to the tumor necrosis factors. These determinations will be accomplished by assessing either the presence of receptors to tumor necrosis factor or the ability of the tumors to synthesize the proteins induced by tumor necrosis factor. The assessment of the responsiveness of the fresh tumor tissues to tumor necrosis factor, as proposed, would not require the growth of the tumor cells in vitro and could be done rapidly, thereby allowing clinicians to select for tumor necrosis factor therapy those patients who are capable of responding to this factor.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA040614-03S1
Application #
3180851
Study Section
Pathology B Study Section (PTHB)
Project Start
1986-05-01
Project End
1989-10-31
Budget Start
1988-05-01
Budget End
1989-10-31
Support Year
3
Fiscal Year
1989
Total Cost
Indirect Cost
Name
New York Blood Center
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10065
Margolis-Nunno, H; Rubin, B Y; Anderson, S L et al. (1990) Isolation of cDNA clones for the interferon-induced 67,000-dalton protein: direct induction of a family of mRNAs by human interferon-alpha and interferon-gamma. J Interferon Res 10:309-19
Squires, K E; Schreiber, R D; McElrath, M J et al. (1989) Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response. J Immunol 143:4244-9
Murray, H W; Szuro-Sudol, A; Wellner, D et al. (1989) Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages. Infect Immun 57:845-9
Rubin, B Y; Anderson, S L; Lunn, R M et al. (1989) Induction of proteins in interferon-alpha- and interferon-gamma-treated polymorphonuclear leukocytes. J Leukoc Biol 45:396-400
Rubin, B Y; Anderson, S L; Lunn, R M et al. (1989) Fragmentation of cellular DNA is a nonspecific indicator of responsiveness to tumor necrosis factor. J Biol Response Mod 8:553-9
Rubin, B Y; Anderson, S L; Lunn, R M et al. (1988) Tumor necrosis factor and IFN induce a common set of proteins. J Immunol 141:1180-4
Rubin, B Y; Smith, L J; Hellermann, G R et al. (1988) Correlation between the anticellular and DNA fragmenting activities of tumor necrosis factor. Cancer Res 48:6006-10
Rubin, B Y; Anderson, S L; Hellermann, G R et al. (1988) The development of antibody to the interferon-induced indoleamine 2,3-dioxygenase and the study of the regulation of its synthesis. J Interferon Res 8:691-702
Rubin, B Y; Anderson, S L; Sullivan, S A et al. (1986) Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor. J Exp Med 164:1350-5